Study Examines Opioid Prescription Rates Among Women of Reproductive Age; What It Means for Pennsylvania

Why it matters locally: This national report on opioid prescription rates among women of reproductive age (15-44) is highly relevant to Pennsylvania. With a population of nearly 13 million, a substantial portion of whom are women in this age group, the high rates of opioid prescriptions during the study period (2008-2012) likely reflect similar trends within the state. Since Pennsylvania has struggled significantly with opioid addiction and overdose deaths in recent years, understanding the historical prescribing patterns among this vulnerable demographic is crucial for informing current prevention and treatment strategies. The report underscores the need for continued monitoring of prescribing practices, expansion of access to alternative pain management options, and targeted interventions to reduce opioid dependence and related complications among women of reproductive age in Pennsylvania. These issues often disproportionately affect families and children, adding weight to the importance.

---

A report in the Morbidity and Mortality Weekly Report (MMWR) has examined the prevalence of opioid painkiller prescriptions among women of reproductive age in the United States between 2008 and 2012. The Centers for Disease Control and Prevention (CDC) released the report. The study focused on women aged 15-44 who were enrolled in either Medicaid or had private insurance. Researchers analyzed prescription data to determine the percentage of women filling at least one opioid prescription each year during the five-year period. The findings indicated that a significant portion of women in this demographic received opioid prescriptions. The report stated that over one-third of reproductive-aged women enrolled in Medicaid filled an opioid painkiller prescription annually. Among women with private insurance, the rate was over one-quarter. The report does not offer reasons for the prescription rates, but it provides a quantification of opioid use among women during their reproductive years. Further research would need to be done to determine the conditions for which the opioids were prescribed, the dosages prescribed, and the long-term outcomes for the respective patients. The scope of the study was limited to the period from 2008 to 2012. Data on more recent trends in opioid prescriptions for this population would provide a more current understanding of the issue.